NCT06885242 - Efficacy and Safety of Cyclopentolate Microdrops for Cycloplegic Refraction in Children | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 6, 2024

Primary Completion Date

November 28, 2025

Study Completion Date

December 5, 2025

Conditions

Cycloplegic Refraction

Interventions

DEVICE

Microdrop instillation of cyclopentolate 1%

1 drop administered through the Nanodropper device adapted to the commercially available multi-dose dropper bottle

DEVICE

Standard drop instillation of cyclopentolate 1%

1 drop administered directly through the commercially available multi-dose dropper bottle

Trial Locations (1)

RECRUITING

Papageorgiou General Hospital, Thessaloniki

All Listed Sponsors

collaborator

Nanodropper, Inc.

INDUSTRY

lead

Aristotle University Of Thessaloniki

OTHER